Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-7,560
Closed -$281K 824
2022
Q2
$281K Hold
7,560
0.01% 584
2022
Q1
$343K Sell
7,560
-652
-8% -$28.5K 0.01% 570
2021
Q4
$395K Buy
8,212
+1,407
+21% +$70.9K 0.01% 534
2021
Q3
$378K Hold
6,805
0.01% 499
2021
Q2
$369K Buy
6,805
+1,705
+33% +$93.6K 0.01% 486
2021
Q1
$286K Buy
5,100
+304
+6% +$15.2K 0.01% 554
2020
Q4
$209K Buy
+4,796
New +$189K 0.01% 657

Other funds holding SRDX

Diversified Trust's SRDX Position: Q3 2022 in Review

Diversified Trust sold out of Surmodics (SRDX) in Q3 2022, closing a stake of 7,560 shares — an estimated $281K sold.

Diversified Trust first reported a position in SRDX in Q4 2020 and held it in 7 quarters. The position peaked at $395K in Q4 2021. 123 funds tracked by Wall St. Rank hold SRDX as of Q3 2022.

  • Diversified Trust reported no remaining Surmodics position as of Q3 2022 after selling out during the quarter.
  • Diversified Trust sold 7,560 Surmodics shares in Q3 2022, an estimated $281K.
  • Diversified Trust first reported a position in Surmodics in Q4 2020 and held it in 7 quarters.
  • Diversified Trust's Surmodics position peaked at $395K in Q4 2021.
  • 123 funds tracked by Wall St. Rank held Surmodics as of Q3 2022.

Based on Diversified Trust's 13F filing for Q3 2022, filed 14 Oct 2022.